PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 47 filers reported holding PIERIS PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 0.07 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $0 | – | 272 | -52.4% | 0.00% | – |
| Q4 2023 | $0 | -100.0% | 572 | -81.8% | 0.00% | – |
| Q3 2023 | $1,000 | – | 3,136 | +25.4% | 0.00% | – |
| Q2 2023 | $0 | – | 2,500 | +1073.7% | 0.00% | – |
| Q3 2022 | $0 | – | 213 | +113.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 100 | -91.9% | 0.00% | – |
| Q4 2021 | $5,000 | -90.0% | 1,242 | -90.4% | 0.00% | – |
| Q2 2021 | $50,000 | +400.0% | 12,975 | +226.0% | 0.00% | – |
| Q1 2021 | $10,000 | -9.1% | 3,980 | -10.5% | 0.00% | – |
| Q4 2020 | $11,000 | – | 4,449 | +444800.0% | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 1 | -100.0% | 0.00% | – |
| Q2 2020 | $7,000 | +133.3% | 2,271 | +70.5% | 0.00% | – |
| Q1 2020 | $3,000 | -75.0% | 1,332 | -48.8% | 0.00% | – |
| Q2 2019 | $12,000 | +100.0% | 2,601 | +158.8% | 0.00% | – |
| Q3 2018 | $6,000 | +500.0% | 1,005 | +552.6% | 0.00% | – |
| Q2 2018 | $1,000 | 0.0% | 154 | +2.7% | 0.00% | – |
| Q4 2017 | $1,000 | -94.4% | 150 | -95.2% | 0.00% | – |
| Q3 2017 | $18,000 | -37.9% | 3,126 | -75.2% | 0.00% | – |
| Q4 2015 | $29,000 | – | 12,586 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 1,360,000 | $6,895,000 | 5.06% |
| Omega Fund Management, LLC | 778,230 | $3,946,000 | 2.91% |
| BVF INC/IL | 5,346,838 | $27,108,000 | 2.65% |
| Virtus ETF Advisers LLC | 152,550 | $773,000 | 0.68% |
| SPHERA FUNDS MANAGEMENT LTD. | 842,632 | $4,272,000 | 0.59% |
| Tekla Capital Management LLC | 2,087,380 | $10,583,000 | 0.40% |
| Schonfeld Strategic Advisors LLC | 828,600 | $4,201,000 | 0.23% |
| Orbimed Advisors | 3,140,000 | $15,920,000 | 0.19% |
| Lombard Odier Asset Management (USA) Corp | 563,878 | $2,859,000 | 0.19% |
| Rhenman & Partners Asset Management AB | 300,000 | $1,521,000 | 0.16% |